{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:33:31Z","timestamp":1762004011111},"reference-count":59,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,5,31]],"date-time":"2007-05-31T00:00:00Z","timestamp":1180569600000},"content-version":"vor","delay-in-days":1976,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Clinical Hypertension"],"published-print":{"date-parts":[[2002,1]]},"abstract":"<jats:p> <jats:italic>In the early stage of hypertension, diastolic blood pressure has greater prognostic importance, but in the elderly, systolic blood pressure is the most important marker of cardiovascular complications. Therefore, the need for more strict control of this component of blood pressure must be reconsidered. The benefit obtained in different studies in the elderly suggests that the treatment of isolated systolic hypertension is associated with a reduction in overall cardiovascular mortality of 22%, in coronary heart disease mortality of 26%, and in stroke mortality of 33%. However, a higher percentage of patients (73%) attain the diastolic goal of &lt;90 mm Hg, while only 34% have systolic pressure reduced to &lt;140 mm Hg. In a review of randomized trials comparing at least four different antihypertensive drugs, significant differences in systolic blood pressure reduction have not been demonstrated, except in black populations, in whom calcium channel blockers and diuretics seem to be more effective. In patients with isolated systolic hypertension, data are inconclusive, but calcium channel blockers and diuretics appear to lower blood pressure to a greater degree than do other antihypertensive drugs. Two main predictors of difficulty in controlling systolic blood pressure are the baseline blood pressure and the presence of diabetes. Other predictors are the duration of arterial hypertension, older age, the presence of target organ damage and associated clinical conditions (myocardial infarction, stroke, chronic renal failure), and an elevated serum uric acid level. It appears that the profile of patients with a poorer therapeutic response includes a greater severity of hypertension and\/or the presence of cardiovascular disease.<\/jats:italic> <\/jats:p>","DOI":"10.1111\/j.1524-6175.2002.00487.x","type":"journal-article","created":{"date-parts":[[2007,5,31]],"date-time":"2007-05-31T08:18:40Z","timestamp":1180599520000},"page":"35-40","source":"Crossref","is-referenced-by-count":17,"title":["Factors Influencing the Systolic Blood Pressure Response to Drug Therapy"],"prefix":"10.1111","volume":"4","author":[{"given":"Carlos","family":"Campo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juli\u00e1n","family":"Segura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis M.","family":"Ruilope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,5,31]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(71)90428-0"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.34.3.386"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.1.308"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1000408"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(99)80316-1"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03460240051027"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)05381-6"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199816120-00016"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92589-T"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.3109\/08037059309077541"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.34.3.381"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.9.1245"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(99)00214-9"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(99)70312-1"},{"key":"e_1_2_6_16_2","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.1982.03330120023025","article-title":"Multiple Risk Factor Intervention Trial: risk factor changes and mortality results","volume":"248","author":"The MRFIT Research Group","year":"1982","journal-title":"JAMA"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199312233292602"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.23.3.275"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.5.1132"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90944-Z"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90878-9"},{"issue":"3","key":"e_1_2_6_22_2","first-page":"S501","article-title":"Influence of hypotensive drug treatment in elderly hypertensives: study terminating events in the trial of the European Working Party on High Blood Pressure in the Elderly (EWPHE)","volume":"3","author":"Amery A","year":"1985","journal-title":"J Hypertens Suppl"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199210000-00001"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)05012-0"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7160.713"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02527-7"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02526-5"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04311-6"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(00)00280-6"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440420033005"},{"key":"e_1_2_6_31_2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/jama.1993.03510060059034","article-title":"Treatment of mild hypertension study (TOMHS): final results","volume":"270","author":"Neaton JD","year":"1993","journal-title":"JAMA"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199304013281303"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199509000-00018"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2001.00448.x"},{"key":"e_1_2_6_35_2","first-page":"1202","article-title":"A comparison of four primary classes of antihypertensive monotherapy in Thai patients","volume":"83","author":"Sukonthesarn A","year":"2000","journal-title":"J Med Assoc Thai"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)90765-Q"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(00)01266-8"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.7.965"},{"key":"e_1_2_6_39_2","first-page":"151","article-title":"World Health Organization\u2010International Society of Hypertension guidelines for the management of hypertension","volume":"17","author":"Guidelines Subcommittee","year":"1999","journal-title":"J Hypertens"},{"key":"e_1_2_6_40_2","first-page":"1955","article-title":"Effects of ACE inhibitors, calcium antagonists, and other blood\u2010pressure\u2010lowering drugs: results of prospectively designed overviews of randomised trials","volume":"355","author":"Blood Pressure Lowering Treatment Trialists' Collaboration","year":"2000","journal-title":"Lancet"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199001000-00003"},{"key":"e_1_2_6_42_2","first-page":"140","article-title":"How can hypertensive patients be treated? The contribution of combined therapy","volume":"9","author":"Benetos A","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"e_1_2_6_43_2","first-page":"S33","article-title":"The heterogeneity of hypertension: Why doesn't every patient respond to every antihypertensive drug","volume":"9","author":"Sever P","year":"1995","journal-title":"J Hum Hypertens"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199001000-00002"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.155.16.1757"},{"issue":"5","key":"e_1_2_6_46_2","first-page":"III36","article-title":"Renin system activity as a determinant of response to treatment of hypertension and heart failure","volume":"5","author":"Cody RJ","year":"1983","journal-title":"Hypertension"},{"key":"e_1_2_6_47_2","first-page":"443","article-title":"Clinical parameters in essential hypertensive patients","volume":"5","author":"De la Sierra A","year":"1991","journal-title":"J Hum Hypertens"},{"issue":"6","key":"e_1_2_6_48_2","first-page":"33","article-title":"Predictors of number of drugs needed to control blood pressure in essential hypertension [abstract]","volume":"25","author":"Ruilope LM","year":"1995","journal-title":"Hypertension"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.35.5.1038"},{"issue":"4","key":"e_1_2_6_50_2","first-page":"S41","article-title":"Predictors of systolic blood pressure control with antihypertensive monotherapy [abstract]","volume":"18","author":"Campo C","year":"2000","journal-title":"J Hypertens"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.287.6385.88"},{"issue":"5","key":"e_1_2_6_52_2","first-page":"S547","article-title":"Blood pressure control in a hypertension clinic","volume":"5","author":"Chatellier G","year":"1987","journal-title":"J Hypertens"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-999-0055-0"},{"issue":"2","key":"e_1_2_6_54_2","first-page":"S75","article-title":"Sodium and potassium intake influence therapeutic needing in essential hypertension [abstract]","volume":"19","author":"Campo C","year":"2001","journal-title":"J Hypertens"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00770.x"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1982.62.2.347"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199405193302008"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199600002-00004"},{"key":"e_1_2_6_59_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-000-0011-5"},{"key":"e_1_2_6_60_2","first-page":"53","article-title":"Clinical features, anthropometric characteristics, and racial influences on the \u201cwhite\u2010coat effect\u201d in a single\u2010center cohort of 1553 consecutive subjects undergoing ambulatory blood pressure monitoring","volume":"5","author":"Gualdiero P","year":"2000","journal-title":"Blood Press Monit"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1524-6175.2002.00487.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1524-6175.2002.00487.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T12:23:06Z","timestamp":1697545386000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1524-6175.2002.00487.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["10.1111\/j.1524-6175.2002.00487.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1524-6175.2002.00487.x","archive":["Portico"],"relation":{},"ISSN":["1524-6175","1751-7176"],"issn-type":[{"value":"1524-6175","type":"print"},{"value":"1751-7176","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}